Cnd Life Sciences Closes Series Seed 3 Round, Reaches $12.5 Million In Total Equity Raised
Round Type
Seed
ScottsdaleBiotechnologyInvestors
Description
CND Life Sciences, a medical technology company pioneering the development of reliable skin-based tests to help clinicians diagnose neurodegenerative disorders like Parkinson's disease and dementia with Lewy bodies, today announced the closing of a $4.5 million Series Seed 3 equity financing round. This follow-on round brings the Company's total Seed financing to $12.5 million to continue accelerating the commercialization of the Syn-One Test®, the first commercially available test that can identify abnormal alpha-synuclein aggregation through a simple skin biopsy. Several existing investors as well as new investors participated in the round, and Top Corner Capital provided a concurrent financing vehicle, demonstrating enthusiasm for CND's strong progress and future.
Quick answer
CND Life Sciences raised an undisclosed amount in a Seed round, dated April 6, 2023. Investors: Top Corner Capital. CND Life Sciences is based in Scottsdale, Arizona, United States.
- How much did CND Life Sciences raise?
- CND Life Sciences raised an undisclosed amount in a Seed round on April 6, 2023.
- Who invested in CND Life Sciences?
- Top Corner Capital is named as investors in this round.
- What does CND Life Sciences do?
- CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other conditions.
- Where is CND Life Sciences based and how big is it?
- CND Life Sciences is based in Scottsdale, Arizona, United States. Fundz records about 150 employees.
- Who are the decision-makers at CND Life Sciences?
- Fundz holds 3 contacts at CND Life Sciences, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as CND Life Sciences that raised within 45 days of this round, from Fundz verified event records.
- SURGE Therapeutics raised $32M on May 19, 2023.
- Hopewell Therapeutics raised $3M (Seed) on May 19, 2023.
- LinusBio raised $8M on May 19, 2023.
- Korsana Biosciences raised $5M on May 19, 2023.
- Artelon raised $20M on May 19, 2023.
- Alphyn Biologics raised $1.2M (Series A) on May 19, 2023.
Who to call at CND Life Sciences, and when
A new round usually means CND Life Sciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CND Life Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CND Life Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CND Life Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CND Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CND Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.